The latest cancer drugs news
Browsing: Cancer Drug News
Researchers identify new drug combo for liver cancer via CRISPR-Cas9 screen
A research team of LKS Faculty of Medicine, The University of Hong Kong (HKUMed) has…
Relatlimab plus nivolumab improves progression-free survival in metastatic melanoma
In patients with untreated, advanced melanoma, the combination of immune checkpoint inhibitors relatlimab and nivolumab…
Decreasing cancer drugs’ side effects
Millions of people around the globe are affected by cancer each year; more than 39%…
Phase I/II study shows increased PFS for patients with r/r multiple myeloma who received ixazomib in combination with pomalidomide and dexamethasone
Early results from an Alliance for Clinical Trials in Oncology randomised clinical trial of adults…
Scientists retool CAR T cells to serve as ‘micropharmacies’
Chimeric antigen receptor (CAR) T cells use genetically engineered versions of a patient’s own immune…
Daratumumab in multiple myeloma: Reassessment shows hint of considerable added benefit
An early benefit assessment conducted by the German Institute for Quality and Efficiency in Health…
ICR responds to NICE decision not to recommend olaparib for advanced prostate cancer
The Institute of Cancer Research, London, UK, has expressed disappointment that NICE has decided not…
Study details chromosome-level changes that allow melanomas to develop drug resistance
Precision therapies targeting melanoma and other cancers have improved patient survival, but tumours often stop…
Novel computational pipeline could help repurpose cancer drugs for rare diseases
By combining computational and experimental approaches, University of Pittsburgh School of Medicine and Prairie View…
Arginine, an inexpensive oral drug, could enhance radiation therapy
Treatment with arginine, one of the amino-acid building blocks of proteins, enhanced the effectiveness of…